Brandt Ralf 4
4 · CANCER GENETICS, INC · Filed May 14, 2018
Insider Transaction Report
Form 4
Brandt Ralf
President, Discovery Services
Transactions
- Award
Stock Option (right to buy)
2018-05-10+150,000→ 150,000 totalExercise: $0.89Exp: 2028-05-10→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Amended and Restated Cancer Genetics, Inc. 2011 Equity Incentive Plan (the "2011 Plan"). The shares underlying the options shall become vested and exercisable with respect to twenty percent (20%) of the shares on the one-year anniversary of the date of grant and with respect to the remaining eighty percent (80%) of the shares in equal monthly installments on the 10th day of each of the forty-eight (48) calendar months thereafter, provided that the optionee remains a services provider to the Company through each applicable vesting period. The exercise price is the closing price of a share of Common Stock as of the date of grant on the NASDAQ Capital Market in accordance with the terms of the 2011 Plan.